Molecular Signatures of Cutaneous Dupilumab Response
Clinical trial NCT05858619 · RECRUITING
Trial details
- NCT number
- NCT05858619
- Sponsor
- University of California, San Francisco
- Status
- RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2023-02-01
- Primary completion
- 2028-02-01
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.